These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37812332)

  • 21. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
    Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
    Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
    Krishna R; Raj J; Dev D; Prasad SC; Reghu R; V SO
    Scand J Gastroenterol; 2020 Jul; 55(7):860-864. PubMed ID: 32634332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
    Belcher JM; Parada XV; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Sharma P; Regner KR; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT; Allegretti AS;
    Am J Kidney Dis; 2022 May; 79(5):737-745. PubMed ID: 34606933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
    Gifford FJ; Morling JR; Fallowfield JA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):593-603. PubMed ID: 28052382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
    Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
    Cavallin M; Kamath PS; Merli M; Fasolato S; Toniutto P; Salerno F; Bernardi M; Romanelli RG; Colletta C; Salinas F; Di Giacomo A; Ridola L; Fornasiere E; Caraceni P; Morando F; Piano S; Gatta A; Angeli P;
    Hepatology; 2015 Aug; 62(2):567-74. PubMed ID: 25644760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study.
    Saif RU; Dar HA; Sofi SM; Andrabi MS; Javid G; Zargar SA
    Indian J Gastroenterol; 2018 Sep; 37(5):424-429. PubMed ID: 30178092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
    Wang H; Liu A; Bo W; Feng X; Hu Y
    Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
    Allegretti AS; Subramanian RM; Francoz C; Olson JC; Cárdenas A
    Liver Int; 2022 Oct; 42(10):2124-2130. PubMed ID: 35838488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
    Wong F; Boyer TD; Sanyal AJ; Pappas SC; Escalante S; Jamil K
    Nephrol Dial Transplant; 2020 Sep; 35(9):1554-1561. PubMed ID: 30887050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hepatorenal syndrome and associated outcomes: a systematic reviews.
    Roozbeh J; Ezzatzadegan Jahromi S; Rezazadeh MH; Hamidianjahromi A; Malekmakan L
    BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38631807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
    Nassar Junior AP; Farias AQ; D' Albuquerque LA; Carrilho FJ; Malbouisson LM
    PLoS One; 2014; 9(9):e107466. PubMed ID: 25203311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2009 Mar; 32(3):133-40. PubMed ID: 19440988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
    Narahara Y; Kanazawa H; Sakamoto C; Maruyama H; Yokosuka O; Mochida S; Uemura M; Fukui H; Sumino Y; Matsuzaki Y; Masaki N; Kokubu S; Okita K
    J Gastroenterol; 2012 Mar; 47(3):313-20. PubMed ID: 22038555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis.
    Malik A; Malik MI; Qureshi S; Nadir A
    Ann Hepatol; 2024; 29(4):101495. PubMed ID: 38460713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.